Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.


Journal Article

Histiocytic sarcoma (HS) is a malignant tumor composed of proliferating cells of histiocytic origin. True HS is exceedingly rare, particularly in pediatric patients. These tumors are frequently aggressive, and outcome for patients with HS has traditionally been poor. There is currently no consensus on the optimal management of these tumors, with the literature consisting largely of case reports and small case series utilizing a wide variety of therapies. We describe a case of HS in an 8-year-old female who was successfully treated with an abbreviated leukemia chemotherapy regimen.

Full Text

Cited Authors

  • Heath, JL; Burgett, SE; Gaca, AM; Jaffe, R; Wechsler, DS

Published Date

  • October 2014

Published In

Volume / Issue

  • 61 / 10

Start / End Page

  • 1874 - 1876

PubMed ID

  • 24888336

Pubmed Central ID

  • 24888336

Electronic International Standard Serial Number (EISSN)

  • 1545-5017

International Standard Serial Number (ISSN)

  • 1545-5009

Digital Object Identifier (DOI)

  • 10.1002/pbc.25100


  • eng